TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED

Autres langues TaiGen Biopharmaceuticals Holdings Limited

Actions

4157

KYG866171005

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 02/07/2024			Varia. 5j.	Varia. 1 janv.
15,05 ^TWD	-0,33%		-0,33%	-0,99%

15/05	TaiGen Biopharmaceuticals Holdings Limited annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
15/03	TaiGen Biopharmaceuticals Holdings Limited publie ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23/08/23
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	09/05/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
TaiGen Biopharmaceuticals Turns to Profit in 2021	17/03/22
TaiGen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/08/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	11/05/21
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2020	25/03/21
TaiGen Biotechnology Company, Limited Partners with GPCR Therapeutics, Inc. to Develop Burixafor & Taigexyn(R)	09/11/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2020	04/11/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2020	04/08/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	29/04/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2019	19/03/20
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Third Quarter Ended September 30, 2019	10/11/19
Taigen Biopharmaceuticals Holdings Limited Reports Earnings Results for the Second Quarter Ended June 30, 2019	12/08/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues TaiGen Biopharmaceuticals Holdings Limited

Actions

4157

KYG866171005

Autres langues

Filtres